Arrowhead Pharmaceuticals, Inc.

INDEPENDENT FINANCIAL GROUP, LLC ARWR

Report date

6/30/2026

Quarter

2026 Q2

Filed

7/15/2026

Shares

14,410

Value ($000)

1,175

Weight

0.0%

2021 Q2 - 2026 Q2 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	7/15/2026	1,175	0.0%	14,410	6/30/2026
2026 Q1	5/15/2026	964	0.0%	15,375	3/31/2026
2025 Q4	5/14/2026	1,066	0.0%	16,050	12/31/2025
2025 Q3	5/15/2026	584	0.0%	16,925	9/30/2025
2025 Q2	5/15/2026	537	0.0%	33,985	6/30/2025
2025 Q1	5/19/2026	507	0.0%	39,783	3/31/2025
2024 Q4	6/12/2026	718	0.0%	38,205	12/31/2024
2024 Q3	6/12/2026	426	0.0%	22,005	9/30/2024
2024 Q2	6/12/2026	285	0.0%	10,950	6/30/2024
2024 Q1	6/12/2026	239	0.0%	8,350	3/31/2024
2023 Q4	6/12/2026	276	0.0%	9,025	12/31/2023
2023 Q3	6/12/2026	202	0.0%	7,500	9/30/2023
2023 Q2	6/12/2026	260	0.0%	7,300	6/30/2023
2022 Q4	6/12/2026	241	0.0%	5,950	12/31/2022
2022 Q3	6/12/2026	216	0.0%	6,525	9/30/2022
2022 Q2	6/12/2026	240	0.0%	6,825	6/30/2022
2022 Q1	6/12/2026	272	0.0%	5,925	3/31/2022
2021 Q4	6/15/2026	353	0.0%	5,325	12/31/2021
2021 Q3	6/15/2026	295	0.0%	4,725	9/30/2021
2021 Q2	6/15/2026	258	0.0%	3,121	6/30/2021